Jane Street Group LLC Buys 39,364 Shares of Core Laboratories Inc. (NYSE:CLB)

Jane Street Group LLC boosted its stake in Core Laboratories Inc. (NYSE:CLB) by 54.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 111,353 shares of the oil and gas company’s stock after acquiring an additional 39,364 shares during the period. Jane Street Group LLC owned 0.24% of Core Laboratories worth $1,928,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the stock. JPMorgan Chase & Co. boosted its holdings in shares of Core Laboratories by 5.8% during the 3rd quarter. JPMorgan Chase & Co. now owns 41,281 shares of the oil and gas company’s stock valued at $765,000 after buying an additional 2,267 shares in the last quarter. Nisa Investment Advisors LLC boosted its holdings in shares of Core Laboratories by 2,688.5% during the 4th quarter. Nisa Investment Advisors LLC now owns 2,426 shares of the oil and gas company’s stock valued at $42,000 after buying an additional 2,339 shares in the last quarter. Boston Trust Walden Corp boosted its holdings in shares of Core Laboratories by 2.7% during the 4th quarter. Boston Trust Walden Corp now owns 617,336 shares of the oil and gas company’s stock valued at $10,686,000 after buying an additional 16,503 shares in the last quarter. Van ECK Associates Corp boosted its holdings in shares of Core Laboratories by 6.3% during the 4th quarter. Van ECK Associates Corp now owns 443,621 shares of the oil and gas company’s stock valued at $7,679,000 after buying an additional 26,237 shares in the last quarter. Finally, Principal Financial Group Inc. boosted its holdings in shares of Core Laboratories by 3.1% during the 4th quarter. Principal Financial Group Inc. now owns 229,096 shares of the oil and gas company’s stock valued at $3,966,000 after buying an additional 6,827 shares in the last quarter. Institutional investors own 97.81% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have recently commented on CLB shares. Citigroup dropped their target price on shares of Core Laboratories from $16.00 to $13.00 and set a “neutral” rating on the stock in a report on Tuesday, May 13th. Stifel Nicolaus dropped their price target on shares of Core Laboratories from $19.00 to $15.00 and set a “hold” rating on the stock in a research note on Tuesday, April 15th. Finally, StockNews.com cut shares of Core Laboratories from a “hold” rating to a “sell” rating in a research note on Friday, April 25th. Two investment analysts have rated the stock with a sell rating and three have given a hold rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $15.00.

Core Laboratories Price Performance

CLB opened at $11.89 on Friday. The company’s 50-day simple moving average is $13.01 and its two-hundred day simple moving average is $16.46. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.71 and a current ratio of 2.32. The stock has a market capitalization of $557.35 million, a P/E ratio of 18.01, a P/E/G ratio of 0.99 and a beta of 1.45. Core Laboratories Inc. has a 52-week low of $10.14 and a 52-week high of $25.13.

Core Laboratories (NYSE:CLB) last released its quarterly earnings data on Wednesday, April 23rd. The oil and gas company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01). The company had revenue of $123.59 million for the quarter, compared to analysts’ expectations of $125.09 million. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. The firm’s revenue for the quarter was down 4.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.19 earnings per share. As a group, analysts predict that Core Laboratories Inc. will post 0.96 EPS for the current year.

Core Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 27th. Investors of record on Monday, May 5th will be given a dividend of $0.01 per share. The ex-dividend date of this dividend is Monday, May 5th. This represents a $0.04 dividend on an annualized basis and a yield of 0.34%. Core Laboratories’s dividend payout ratio (DPR) is 6.78%.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.